Fig. 4: Overall survival of patients with AML harboring clinically relevant mutations who were grouped by age intervals.
A Patients with IDH1 mutations, B IDH2 mutations, C FLT3-ITD, and D FLT3-TKD.
Fig. 4: Overall survival of patients with AML harboring clinically relevant mutations who were grouped by age intervals. | Leukemia
